课题基金 / 基金详情

Task V12: Clinical Sample Testing for SARS-CoV-2 Vaccine Candidates

Task V12: Clinical Sample Testing for SARS-CoV-2 Vaccine Candidates
任务 V12：SARS-CoV-2 候选疫苗的临床样本测试
批准号：
10267386
负责人：
THOMAS RUDGE
金额：
$639.85万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-09-18 至 2022-09-17
来源：
https://reporter.nih.gov/project-details/10267386
关键词：
2019-nCoVBiologicalBioterrorismCOVID-19ClinicalCommunicable DiseasesContractsDevelopmentEmerging Communicable DiseasesFeasibility StudiesPhaseSamplingServicesTestingToxicity TestsVaccinesassay developmentefficacy testingevaluation/testingimmunogenicitynovel coronavirusnovel vaccinesproduct developmentsafety testingtesting servicesvaccine candidatevaccine development

项目摘要

项目成果

THOMAS RUDGE的其他基金

相似基金

相关文献

中文摘要
翻译
传染病疫苗和其他生物制剂的评估和测试服务（ETS）合同提供了从早期可行性研究到I/II期材料生产的各种产品开发服务，包括检测开发;免疫原性和有效性测试;临床和非临床样品测试;以及安全性和毒性测试。 这些服务将促进开发和引进新的疫苗和生物制剂，以对付潜在的生物恐怖主义制剂以及新出现和重新出现的传染病。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task V18: STUDY TO EVALUATE THE EFFICACY OF TOXIN IN ANIMAL MODEL
TASK V17: DEVELOPMENT OF ASSAYS AND REAGENTS FOR MONKEYPOX VACCINES
TASK V13: DEEP ANTIBODY PROFILING FOR INFECTION AND VACCINATION
Task V12: CLINICAL SAMPLE TESTING FOR ZIKA VIRUS VACCINES
海外基金